title: Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Karin
authors.initials: K
authors.lastname: Leunen
mesh_terms: D017024:Chemotherapy, Adjuvant; D005260:Female; D006176:Gynecology / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D020360:Neoadjuvant Therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010818:Practice Patterns, Physicians'; D014481:United States